Form 4 Tracker
Pamela Wapnick

Chief Financial Officer · 4 filings · Latest: Sep 8, 2026

Metagenomi Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MGX
Pamela WapnickChief Financial OfficerSep 8, 2026
Sale
$1.161,911$2.2K206,580
MGX
Pamela WapnickChief Financial OfficerJun 5, 2026
Sale
$1.302,884$3.7K208,491
MGX
Pamela WapnickChief Financial OfficerMar 5, 2026
Sale
$1.601,581$2.5K187,375